ETO metabolites were found in CSF months after implantation, 5/7 patients had CSF eosinophilia, 0/7 patients had peripheral eosinophilia, 2/7 patients had detectable serum IgE against albumin-ETO and experienced multiple shunt malfunctions without evidence of infection. This evidence concerns the gene IGHE and Increased total eosinophil count.